Home / Peptides / DementiaPeptides.ca
Two fields joined in one phrase, held on Canada's research extension.
Peptides sit at the centre of how neurodegeneration is studied — amyloid-beta is itself a peptide fragment, and peptide chemistry runs through much of the diagnostic and investigational work around cognitive decline. Pairing that with dementia produces a name that states a research territory rather than a product, which is exactly the register serious groups in this space want.
Canada's .ca extension signals institutional footing: a university lab, a CIHR-funded consortium, a Canadian biotech, or a national patient and caregiver information project. Names built from initialisms mean nothing outside the group that chose them, and cheerful brand coinages sit poorly beside peer-reviewed work. This phrase tells a grant reviewer, a clinician, and a family member the same thing in the same three words.
Well suited to
Ideal owner A Canadian research institute or neuroscience-focused biotech.
Lease DementiaPeptides.ca on a flexible monthly term and put a stronger brand to work immediately. You can also make an offer to acquire it outright. Transactions are handled discreetly and can be escrow-secured.
